Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more
Sam-A Pharm. Co. Ltd (009300) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩719.70 Million) by net assets (₩224.41 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sam-A Pharm. Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Sam-A Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sam-A Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
W S Industries (I) Limited
NSE:WSI
|
-0.416x |
|
Neonode Inc
NASDAQ:NEON
|
-0.057x |
|
Jericho Oil Corp
PINK:JROOF
|
-0.016x |
|
Arizona Lithium Limited
PINK:AZLAF
|
-0.046x |
|
AJ Advance Technology Public Company Limited
BK:AJA
|
-0.004x |
|
National Plastic Co Ltd Preferred
KO:004255
|
0.027x |
|
Shinih Enterprise Co Ltd
TW:9944
|
0.008x |
|
Air T Inc
NASDAQ:AIRT
|
-3.137x |
Annual Cash Flow Conversion Efficiency for Sam-A Pharm. Co. Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Sam-A Pharm. Co. Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩219.98 Billion | ₩25.25 Billion | 0.115x | +10.83% |
| 2023-12-31 | ₩200.47 Billion | ₩20.76 Billion | 0.104x | -4.59% |
| 2022-12-31 | ₩180.62 Billion | ₩19.60 Billion | 0.109x | +44.26% |
| 2021-12-31 | ₩172.02 Billion | ₩12.94 Billion | 0.075x | +32.98% |
| 2020-12-31 | ₩166.29 Billion | ₩9.41 Billion | 0.057x | -28.04% |
| 2019-12-31 | ₩168.15 Billion | ₩13.22 Billion | 0.079x | -0.82% |
| 2018-12-31 | ₩160.90 Billion | ₩12.76 Billion | 0.079x | +142.87% |
| 2017-12-31 | ₩156.10 Billion | ₩5.10 Billion | 0.033x | -53.85% |
| 2016-12-31 | ₩148.92 Billion | ₩10.53 Billion | 0.071x | -8.33% |
| 2015-12-31 | ₩140.08 Billion | ₩10.81 Billion | 0.077x | -9.06% |
| 2014-12-31 | ₩134.15 Billion | ₩11.38 Billion | 0.085x | -26.49% |
| 2012-12-31 | ₩121.33 Billion | ₩14.00 Billion | 0.115x | +21.89% |
| 2011-12-31 | ₩110.58 Billion | ₩10.47 Billion | 0.095x | +89.49% |
| 2010-12-31 | ₩101.99 Billion | ₩5.10 Billion | 0.050x | +147.91% |
| 2009-12-31 | ₩79.92 Billion | ₩-8.33 Billion | -0.104x | -- |